Article Text

Download PDFPDF
Methylprednisolone injection improved symptoms for 1 year in patients with the carpal tunnel syndrome

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


 
 QUESTION: What is the effectiveness of a methylprednisolone injection in patients with the carpal tunnel syndrome?

Design

Randomised (allocation concealed*), blinded (clinician, patient, and outcome assessor),* placebo controlled trial with 1 year follow up.

Setting

Outpatient neurology clinic in a district general hospital in the Netherlands.

Patients

Patients >18 years of age (mean age 52 y, 83% women) who had signs and symptoms of the carpal tunnel syndrome for ≥3 months confirmed by electrophysiological tests. Patients who had already been treated for the carpal tunnel syndrome were excluded. Follow up was 100%.

Intervention

Patients were allocated to receive a single injection of methylprednisolone, 40 mg, and lignocaine, 10 mg (intervention …

View Full Text

Footnotes

  • Source of funding: no external funding.

  • For correspondence: Dr J W Dammers, Department of Neurology, Medical Centre Alkmaar, PO Box 501, 1800 AM Alkmaar, the Netherlands.

  • * See glossary.